Like Mango Health

announced 9/11/2019 via PR Newswire

TrialCard, will acquire Mango Health

synopsis: TrialCard, a company that provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers, announced it will acquire Mango Health, the leading provider of mobile-based medication management and adherence solutions for the life sciences sector.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard Incorporated provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers. TrialCard has connected over 30 million patients with nearly $12 billion in branded drug savings to date. "
target: Mango Health
Mango Health is the leading digital medication management platform. It provides a critical support tool to help patients manage medications, stay on track, and have fun in the process. For payers, the platform provides a crucial window into patients' daily lives and a platform for interventions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2020 via BNC Analysis

Walmart, acquired CareZone

synopsis: Walmart, the largest retailer in the world, has acquired CareZone’s medication management technology and intellectual property. CareZone makes it easy to manage multiple medications and organize health information from your smartphone.
buyer: Walmart (WMT:$572,754.00)
Walmart is the largest retailer in the world. Each week, nearly 265 million customers and members visit approximately 11,500 stores under 56 banners in 27 countries and eCommerce websites. Walmart employs over 2.2 million associates worldwide. "
target: CareZone
CareZone makes it easy to manage multiple medications and organize health information from your smartphone. CareZone provides a safe, simple, accessible place to organize the information, and coordinate the people and processes involved in caring for someone in need - a child, a parent or loved one.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/14/2018 via BNC Analysis

Co-op, acquired DIMEC

synopsis: Co-op, the Manchester-based consumer co-operative group ,bought healthcare technology start-up Dimec which enables patients and their General Practitioner (GPs) to interact and manage prescriptions. DIMEC is the free and easy way of ordering prescriptions 24/7.
buyer: Co-op
Co-op is one of the world’s largest consumer co-operatives, owned by millions of members. Co-op is the UK’s sixth biggest food retailer with more than 2,500 local, convenience and medium-sized stores. Co-op is also the UK's number 1 funeral services provider, a major general insurer, and more. "
target: DIMEC
UK-based Healthcare technology platform Dimec has developed an app that enables patients and their General Practitioners (GPs) to interact and better manage their prescription needs. DIMEC is the free and easy way of ordering prescriptions 24/7.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/23/2017 via PR Newswire

Digital Pharmacist Inc., acquired PocketRx App

synopsis: Digital Pharmacist Inc., a rapidly growing digital health company, announced that it has acquired PocketRx, a mobile app that allows patients to manage their prescriptions. Over three hundred pharmacy brands including multi-store locations use the PocketRx app.
buyer: Digital Pharmacist Inc.
Digital Pharmacist Inc. is a rapidly growing digital health company that offers an omni-channel patient engagement platform for 6,000 pharmacies, national pharmacy wholesalers, hospital systems and pharmaceutical brands. Four million patients use the company's products every month. "
target parent: Praeses, LLC.
target: PocketRx App
PocketRx is a mobile app that allows patients to manage their prescriptions. Over three hundred pharmacy brands including multi-store locations such as Denver Health Pharmacy, USave Pharmacy and Owen's Healthcare use the PocketRx app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/16/2020 via BNC Analysis

Fuming Yang, acquired Kelinda

synopsis: Fuming Yang, a Chinese entrepreneur, has acquired a 99% stake in Kelinda, a healthcare focused software company in Moldova. Kelinda offers a mobile app that features various health control panels and reminders. The app allows users to more easily monitor the condition of their health with reminders and notifications for medication and appointments.
buyer: Fuming Yang
Fuming Yang is a Chinese entrepreneur. Fuming Yang is the founder of Liuzhou Bangfu Technology Co., Ltd., a company focusing on internet technology development, maintenance and services. Mr. Yang was also involved in various media projects, such as Star Avenue on CCTV. "
target: Kelinda
Kelinda is a healthcare focused software company in Moldova. Kelinda offers a mobile app that features various health control panels and reminders. The app allows users to more easily monitor the condition of their health with reminders and notifications for medication and doctor appointments.
price ($mm)
$0.33*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/31/2016 via BNC Analysis

MedAdvisor Limited, acquired Healthnotes

synopsis: MedAdvisor has announced the acquisition of Healthnotes, a leader in healthcare technology for medication adherence management. Healthnotes' core platform promotes patient medication adherence, along with pharmacy loyalty by offering prescription management services to patients.
buyer: MedAdvisor Limited (ASX:MDR:$26.91)
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records. "
target: Healthnotes
Healthnotes is a privately held Melbourne based healthcare technology company with an innovative platform that manages patient messaging and medication adherence across multiple demographics.
price ($mm)
$4.19
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2020 via BNC Analysis

GoodRx, Inc., acquired Scriptcycle LLC

synopsis: GoodRx, a website and a mobile app that gathers current prices, powerful savings tips and valuable discounts for every prescription drug at virtually every pharmacy in the US, has acquired Scriptcycle, a healthcare technology company that provides prescription processing and adjudication services to patients, pharmacies, and employers.
buyer parent: Francisco Partners Management LLC
buyer: GoodRx, Inc. (NasdaqGS:GDRX:$745.42)
GoodRx helps Americans save on their prescriptions. It offers a website and a mobile app that gathers current prices, powerful savings tips and valuable discounts for every prescription drug at virtually every pharmacy in the US. "
target: Scriptcycle LLC
Scriptcycle is a healthcare technology company that provides prescription processing and adjudication services to patients, pharmacies, and employers. They offer Prescription Processing & Adjudication, Preferred Prescription Savings Programs, and Transparent Prescription Benefit Management.
price ($mm)
$57
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/22/2022 via PR Newswire

Transaction Data Systems, will acquire Prescribe Wellness

synopsis: Transaction Data Systems, a provider of pharmacy management software, will acquire PrescribeWellness from Tabula Rasa HealthCare, a healthcare technology company. PrescribeWellness is a provider of patient relationship management solutions that enable community pharmacies to improve patient medication adherence, loyalty, and health outcomes.
buyer parent: BlackRock, Inc.
buyer: Transaction Data Systems
Transaction Data Systems (TDS) is a leading provider of pharmacy management software. TDS provides innovative pharmacy management solutions and clinical applications that adapt to the needs of community pharmacy, including their Rx30 and Computer-Rx pharmacy systems. "
target parent: Tabula Rasa Healthcare
target: Prescribe Wellness
PrescribeWellness is a provider of best-in-class patient relationship management solutions. PrescribeWellness provides solutions to help community pharmacies expand their role and provide enhanced services to improve patient medication adherence, loyalty, and health outcomes.
price ($mm)
$125
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/10/2021 via GlobeNewswire

CareDx, Inc, acquired MedActionPlan.Com, LLC

synopsis: CareDx, Inc., a leading precision medicine company, announced it has acquired MedActionPlan, a healthcare solutions company that specializes in the development of web-based and mobile applications. MedActionPlan programs have been shown to reduce medication errors, improve patient understanding and adherence to medication therapy.
buyer: CareDx, Inc (CDNA:$275.82)
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions along the pre- and post-transplant patient journey. "
target: MedActionPlan.Com, LLC
MedActionPlan is a healthcare solutions company that specializes in the development of web-based and mobile applications. MedActionPlan programs have been shown to reduce medication errors, improve patient understanding and adherence to medication therapy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/11/2021 via BusinessWire

Jack Nathan Medical Corp., will acquire Writi Inc.

synopsis: Jack Nathan, one of Canada’s largest healthcare networks, has closed an agreement to acquire Writi Inc., a cloud-based medication-management software platform, available on mobile devices and web platforms. The platforms support the secure digital communication, record maintenance and workflow of resident-related orders and documentation.
buyer: Jack Nathan Medical Corp. (TSXV:JNH:$3.11)
Jack Nathan Medical, operating as Jack Nathan Health, is one of Canada’s largest healthcare networks. Jack Nathan is an innovative healthcare company that is improving access for millions of patients by co-locating physician and ancillary medical services conveniently located inside Walmart stores. "
target: Writi Inc.
Writi is a cloud-based medication-management software platform, available on mobile devices and web platforms. The platforms support the secure digital communication, record maintenance and workflow of resident-related orders and documentation.
price ($mm)
$0.80
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/21/2020 via PR Newswire

HealthVerity, acquired Curisium

synopsis: HealthVerity, the leader in privacy-protected data exchange, announced that it has acquired Curisium, an innovator in cloud-based drug rebate processing and contract performance management.
buyer: HealthVerity
HealthVerity has emerged as a leader and key partner to nearly 75% of top pharmaceutical manufacturers and payers, having fundamentally changed the way that key healthcare organizations secure, exchange and synthesize HIPAA-protected information at scale. "
target: Curisium
Curisium is an innovator in cloud-based drug rebate processing and contract performance management. Curisium's cutting-edge platform enables payers, pharmaceutical manufacturers and providers to enter into innovative contracting arrangements in a secure, efficient, scalable, data-driven way.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/11/2020 via Company Press Release

InVitae, will acquire YouScript, Inc.

synopsis: Invitae Corportation, a leading medical genetics company, will acquire YouScript, a clinical decision support and analytics platform that enables more proactive medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
buyer: InVitae (NVTA:$460.45)
Invitae Corporation is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service. "
target: YouScript, Inc.
YouScript a clinical decision support and analytics platform that enables faster, more proactive personalized medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via GlobeNewswire

Tabula Rasa Healthcare, acquired Prescribe Wellness

synopsis: Tabula Rasa HealthCare, a healthcare technology company advancing the field of medication safety, announced that it has acquired PrescribeWellness, a leading cloud-based patient relationship management solutions company that facilitates collaboration between more than 10,000 pharmacies with patients, payers, providers and pharmaceutical companies.
buyer: Tabula Rasa Healthcare (TRHC:$339.59)
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize patient outcomes, lower healthcare costs and improve organizational performance. "
target: Prescribe Wellness
PrescribeWellness is a leading cloud-based patient relationship management solutions company that facilitates collaboration between more than 10,000 pharmacies with patients, payers, providers and pharmaceutical companies.
price ($mm)
$150
rev ($mm)
$29
EBITDA ($mm)
$0
EV / rev
5.2x
EV / EBITDA
500.0x
closed 4/28/2014 via BusinessWire

Accolade, Inc., acquired konciergeMD

synopsis: Accolade, an innovative consumer engagement company, has acquired konciergeMD, a cloud-based consumer engagement company, singularly focused on helping patients and their families work more closely with their care team to improve outcomes. The acquisition will enahnce Accolade's leading consumer healthcare engagement service.
buyer: Accolade, Inc. (:$155.57)
Accolade uses their Accolade Health Assistants- a single point of contact for any health benefit or healthcare need, to improve people's healthcare experience while lowering costs for large employers, payers and Accountable Care Organizations. "
target: konciergeMD
konciergeMD is a first-of-its-kind, cloud-based consumer engagement company, singularly focused on helping patients and their families work more closely with their care team to improve outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/8/2020 via BNC Analysis

IngenioRx, acquired Zipdrug, Inc.

synopsis: Anthem’s pharmacy benefit manager, IngenioRx, has acquired Zipdrug, a healthcare company that facilitates in-home drug delivery and helps health plans track medication adherence. The acquisition gives IngenioRx access to Zipdrug’s services and the ability to sell them to health plans as part of its offering or as a standalone pharmacy service.
buyer parent: Anthem, Inc.
buyer: IngenioRx
IngenioRx provides pharmacy benefit management services to payers, including affiliates of Anthem, Inc. The company offers a whole health approach that helps drive better outcomes and lowers member, employer, and plan costs. "
target: Zipdrug, Inc.
ZipDrug is a data-driven healthcare company bringing better outcomes to patients and payers and increased revenue and reputation to partner pharmacies. ZipDrug simplifies the pharmacy experience by connecting patients to pharmacies and delivering lower cost prescriptions directly to their door.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/29/2016 via PR Newswire

Decision Resources Group, acquired Adaptive Software LLC

synopsis: Decision Resources Group (DRG) announced that it has acquired Adaptive Software. The company is a group of developers of market-leading pharmacy benefit and formulary management software platforms.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group (DRG), a subsidiary of Piramal Enterprises Ltd., offers best-in-class, high-value data, analytics and insights products and services to the healthcare industry, delivered by more than 900 employees across 15 offices in North America, Europe and Asia. "
target: Adaptive Software LLC
Adaptive Software, located in Kansas City, currently offers to health plans and Pharmacy Benefit Managers (PBMs) a suite of software solutions that streamlines formulary management, pharmacy networking, pricing, and pharmacy benefit design.
price ($mm)
$7.40
rev ($mm)
$3
EBITDA ($mm)
EV / rev
7.7x
EV / EBITDA
closed 10/15/2012 via GlobeNewswire

ExlService Holdings, Inc., acquired Landacorp, Inc.

synopsis: ExlService Holdings, Inc. announced it has acquired Landacorp Inc., significantly increasing its capabilities to serve the healthcare industry. Landacorp is a leading provider of healthcare solutions and technology with more than 50 million members under management on its platforms.
buyer: ExlService Holdings, Inc. (EXLS:$1,075.76)
ExlService Holdings, Inc. is a leading provider of outsourcing and transformation services. EXL primarily serves the needs of Global 1000 companies from global delivery centers in the insurance, healthcare, utilities, banking and financial services, transportation and logistics, and travel sectors. "
target parent: Welsh, Carson, Anderson & Stowe
target: Landacorp, Inc.
Landacorp's flagship CareRadius suite is a flexible platform designed to integrate a payer's internal and external data to streamline workflows, support collaboration among healthcare professionals and drive better health decision making with analytics.
price ($mm)
$38
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/27/2022 via PR Newswire

Mymee, acquired Breakthrough Health

synopsis: Mymee, a leading provider of specialized care and support for people with autoimmune diseases, has acquired Breakthrough Health, a digital health startup based in Berlin. Breakthrough Health's Emilyn app enables people living with multiple sclerosis to track their symptoms, set medication reminders, and securely share their health records.
buyer: Mymee
Mymee is a leader in precision health and nutrition. Mymee empowers people with autoimmune diseases to make sense of and manage their symptoms. They provide patients with virtual, one-on-one sessions with a certified health coaches to help them find what triggers their symptoms. "
target: Breakthrough Health
Breakthrough Health is a digital health startup based in Berlin. Breakthrough Health's Emilyn app empowers people living with multiple sclerosis to understand their condition better. The app allows users to track their symptoms, set medication reminders, and securely share their health records.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/30/2022 via BusinessWire

Linus Health, acquired Kinesis Health Technologies

synopsis: Linus Health, a Boston-based digital health company focused on brain health, announced the completion of its acquisition of Kinesis Health Technologies, a Dublin-based leader in physical function assessment for older adults.
buyer: Linus Health
Linus Health is a digital health company focused on transforming brain health for people across the world. By advancing how we detect, diagnose, and address cognitive and brain disorders, their goal is to enable a future where people can live longer and healthier lives with better brain health. "
target: Kinesis Health Technologies
Kinesis Health Technologies Limited is an award-winning digital health company based in Dublin, Ireland. Kinesis solutions utilize sensors, artificial intelligence, and machine learning to produce comprehensive and accurate assessments of gait, mobility, balance, and falls risk in older adults.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/16/2022 via BusinessWire

Medable, acquired Omhu A/S

synopsis: Medable Inc., the leading software provider for patient-centered clinical trials, announced that it has acquired LEO Innovation Lab’s Omhu A/S, a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions.
buyer: Medable
Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention and data quality for decentralized trials. "
target parent: LEO Pharma Inc.
target: Omhu A/S
Omhu is a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions. Omhu’s software applications include Imagine, a skin-tracking mobile app, and Omhu Care, a telemedicine app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/11/2019 via PR Newswire

TrialCard, will acquire Mango Health

synopsis: TrialCard, a company that provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers, announced it will acquire Mango Health, the leading provider of mobile-based medication management and adherence solutions for the life sciences sector.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard Incorporated provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers. TrialCard has connected over 30 million patients with nearly $12 billion in branded drug savings to date. "
target: Mango Health
Mango Health is the leading digital medication management platform. It provides a critical support tool to help patients manage medications, stay on track, and have fun in the process. For payers, the platform provides a crucial window into patients' daily lives and a platform for interventions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/11/2019 via PR Newswire

TrialCard, will acquire Mango Health

synopsis: TrialCard, a company that provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers, announced it will acquire Mango Health, the leading provider of mobile-based medication management and adherence solutions for the life sciences sector.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard Incorporated provides patient affordability, medication access and adherence, and patient support services on behalf of pharmaceutical manufacturers. TrialCard has connected over 30 million patients with nearly $12 billion in branded drug savings to date. "
target: Mango Health
Mango Health is the leading digital medication management platform. It provides a critical support tool to help patients manage medications, stay on track, and have fun in the process. For payers, the platform provides a crucial window into patients' daily lives and a platform for interventions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/17/2019 via Company Press Release

TrialCard, acquired RxSolutions

synopsis: TrialCard, a company that offers customized patient access solutions exclusively for the pharmaceutical industry, has acquired RxSolutions, a privately-held company specializing in customized pharmaceutical reimbursement-based programs for both the marketing and clinical supply professional.
buyer parent: Odyssey Investment Partners
buyer: TrialCard
TrialCard offers customized patient access solutions exclusively for the pharmaceutical industry in support of product marketing, patient assistance programs, and phase IV clinical trials. TrialCard innovates by focusing on client brands and analyzing new trends in prescription optimization. "
target: RxSolutions
RxSolutions is a privately-held company with more than 20 years experience specializing in customized pharmaceutical reimbursement-based programs for both the marketing and clinical supply professional. They are known for their dedication to customer care at a remarkable value.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2013 via BNC Analysis

DrugDev, acquired CFS Clinical

synopsis: DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials.
buyer: DrugDev
DrugDev helps the clinical trials industry run faster, cheaper and smarter trials. Experienced Investigators choose to be part of the free network to access new clinical trial opportunities they would not otherwise have learnt about. "
target: CFS Clinical
CFS Clinical (CFS) is a technology-enabled service provider focused on the business and financial management activities for clinical trials.CFS’ experts deliver best-in-class Investigator site payment and study startup solutions around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/13/2016 via BusinessWire

Vitruvian Partners LLP, acquired Phlexglobal

synopsis: Phlexglobal, the thought leaders and specialists in the provision of electronic Trial Master File systems and services to the life sciences industry, announced an investment by Vitruvian Partners. The transaction establishes Vitruvian as majority shareholder of Phlexglobal, while previous majority investor Bridgepoint will exit the company.
buyer: Vitruvian Partners LLP
Vitruvian Partners is an independent European private equity firm that invests in high-growth Dynamic Situations. They focus on asset-light companies in targeted sectors with strong, sustainable growth, and in companies driven by new competitive advantage, a transition in business model, or events. "
target parent: Bridgepoint
target: Phlexglobal
Phlexglobal is a specialist provider of technology-enabled, Trial Master File (TMF & eTMF) document management solutions and other support services to the global clinical research market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/14/2014 via Company Press Release

Bridgepoint, acquired Phlexglobal

synopsis: Phlexglobal, the specialist provider of technology-enabled document management solutions and other support services to the global clinical research market, has been acquired by Bridgepoint Development Capital from Inflexion in a transaction totalling £42 million.
buyer: Bridgepoint (:$353.32)
Bridgepoint is one of the most experienced private equity investment firms based in Europe. With a clear, long-term focus on sectors where it can invest in robust middle market companies, it typically acquires businesses valued between €200 million and €1 billion. "
target parent: Inflexion Private Equity Partners LLP
target: Phlexglobal
Phlexglobal is a specialist provider of technology-enabled, Trial Master File (TMF & eTMF) document management solutions and other support services to the global clinical research market.
price ($mm)
$72
rev ($mm)
$25
EBITDA ($mm)
$7
EV / rev
2.8x
EV / EBITDA
9.6x
announced 7/18/2012 via BusinessWire

Adjility Health will be merged with Alliance Life Sciences Consulting Group, Inc,

synopsis: Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, and Adjility Consulting, a consulting firm specializing in management consulting and analytic solutions for clinical operations and the global market access, pricing and reimbursement space, announced that the two companies will merge.
buyer: Alliance Life Sciences Consulting Group, Inc
Alliance Life Sciences Consulting Group employs more than 175 professionals who collectively understand the business challenges of the Life Sciences industry and offer solutions for Sales & Marketing, Managed Care & Government Contracting, Commercial Operations, Information Management and Analytics."
target: Adjility Health
Adjility Health is dedicated to helping healthcare companies improve their operations through the use of strategic consulting services and very industry domain-specific analytic, forecasting, predictive trending and other data insight tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/26/2012 via BusinessWire

Accenture, acquired Octagon Research Solutions, Inc.

synopsis: Accenture completed its acquisition of Octagon Research Solutions, a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry. The acquisition enhances Accenture's existing clinical services capabilities – including clinical data management, clinical programming and safety case processing.
buyer: Accenture (ACN:$53,736.36)
Accenture is a global management consulting, technology services and outsourcing company. Accenture collaborates with clients to help them become high performance businesses and governments. "
target parent: Edison Ventures
target: Octagon Research Solutions, Inc.
Octagon Research Solutions is the world leader in clinical and regulatory information management solutions to the life sciences industry. Through an integrated suite of outsourced services, strategic consulting, and innovative technology, Octagon optimizes the entire drug development lifecycle.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/9/2022 via Yahoo, Inc.

M&B Sciences Inc., acquired Clara Health

synopsis: M&B Sciences Inc, a fast-growing African-American owned, technology-driven clinical research organization, announces the acquisition of Clara Health, a company dedicated to using technology to increase access to clinical trials. Clara Health was created in 2015 to make it simple for patients to find clinical trials that fit them best.
buyer: M&B Sciences Inc.
Established in 2016, M&B Sciences, Inc. is a California based, technology driven, minority owned Contract Research Organization that supports pharmaceutical and biotech sponsors. Their leadership has over 100 years of combined experience within the life sciences and healthcare industry. "
target: Clara Health
Clinical trials are the longest and most expensive step in bringing a new treatment to market. Clara Health was created in 2015 from a collaboration with patient advocates to make it simple and approachable to find and connect to clinical trials that fit them best.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$8,793.96)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 12/16/2016 via PR Newswire

Indegene Lifesystems Pvt Ltd., acquired Wincere, Inc.

synopsis: Indegene, a global healthcare solutions provider, announced the acquisition of Wincere Inc. Wincere is a leading clinical data management and clinical and statistical programming solutions provider located on the West Coast in Silicon Valley, CA. Wincere is deeply engaged with clinical R&D needs of many emerging biopharma companies.
buyer: Indegene Lifesystems Pvt Ltd.
Indegene enables global healthcare organizations to address complex challenges by seamlessly integrating analytics, technology, operations and medical expertise and drives better health and business outcomes. "
target: Wincere, Inc.
Wincere provides smarter clinical research services across all clinical trial phases by using its patent-pending technology to support clinical trial startup, conduct, and submission activities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/27/2018 via Company Press Release

The WIRB-Copernicus Group, acquired ACI Clinical

synopsis: WIRB-Copernicus Group, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, has acquired ACI Clinical, a specialty provider of clinical trial committees and clinical trial advisory services.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ACI Clinical
ACI Clinical is a specialty provider of clinical trial committees and clinical trial advisory services. ACI Clinical specializes in clinical and safety consulting, including full service Endpoint Adjudication Committees and Data Monitoring Committees.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2014 via BNC Analysis

Synchrogenix Information Strategies, Inc. merged with Certara,

synopsis: Arsenal Capital Partners have acquired Synchrogenix Information Strategies Inc., which will merge with Certara LP. Synchrogenix, a specialty contract research organization providing strategic regulatory writing and related services to pharmaceutical, biotechnology, and medical device companies worldwide.
buyer parent: Arsenal Capital Partners
buyer: Certara (:$261.77)
Certara™ is dedicated to improving human health through a broad spectrum of software products and services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. "
target: Synchrogenix Information Strategies, Inc.
Synchrogenix is a specialty contract research organization providing strategic regulatory writing and related services to pharmaceutical, biotechnology, and medical device companies worldwide. The company offers pre-clinical, clinical, CMC, and drug safety writing and submission services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/4/2013 via PR Newswire

Accelera Innovations, Inc., will acquire Behavioral Health Care Associates, Ltd.

synopsis: Accelera Innovations, Inc., a provider of cloud based software-as-a-service solutions to the healthcare industry announced that they have signed a stock purchase agreement to acquire 100% of Behavioral Health Care Associates, Ltd., a provider of billing, practice management and administrative services to doctors and other clinicians.
buyer: Accelera Innovations, Inc.
Accelera Innovations, Inc. offers cloud based software-as-a-service solutions to the healthcare industry that includes technology and services to providers and payers, who are seeking to create an interoperable technology platform that is patient-centric. "
target: Behavioral Health Care Associates, Ltd.
Behavioral Health Care Associates, Ltd. provides billing, practice management and administrative services to doctors and other clinicians who provide services to hospitals, nursing homes and individual clients.
price ($mm)
$4.55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/20/2012 via PR Newswire

ePharmaSolutions, Inc., acquired Polaris Biopharma Consulting

synopsis: ePharmaSolutions announced the acquisition of Polaris BioPharma Consulting, a leading global patient recruitment and retention firm headquartered in Slough, UK. Polaris Biopharma was founded in 1999 as a boutique patient recruitment and retention firm supporting global pharmaceutical companies.
buyer: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology. "
target: Polaris Biopharma Consulting
Polaris Biopharma Consulting is a boutique patient recruitment and retention firm. Polaris has helped large and mid-sized pharmaceutical companies and CROs develop and deploy hundreds of global feasibility, trial optimisation and patient recruitment programs in every major therapeutic area.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2006 via BusinessWire

Applied Clinical Intelligence merged with TAKE Solutions, Inc.,

synopsis: TAKE Solutions, Inc. announced the formation of the OneClinical brand of life sciences offerings as part of its merger with Applied Clinical Intelligence and OnSphere Corporation. OneClinical combines a full spectrum of proven data and document management software products and services for clinical trials, drug and device development lifecycles.
buyer parent: Shriram Group
buyer: TAKE Solutions, Inc. (BSE:532890:$259.76)
TAKE Solutions is a leading international business technology company with products backed by a strong domain expertise to provide cost-effective comprehensive solutions for businesses. "
target: Applied Clinical Intelligence
Applied Clinical Intelligence was founded in 2001 to provide data-driven solutions for clinical trials and risk management programs. ACI is a specialized clinical services group offering strategic, operational, and technical intelligence.
price ($mm)
$4.71
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2017 via PR Newswire

The WIRB-Copernicus Group, acquired ProPhase, LLC

synopsis: WIRB-Copernicus Group® (WCG™), the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, announced that it has acquired ProPhase. ProPhase is a global provider of measurement-related specialty solutions in clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ProPhase, LLC
ProPhase is a global provider of measurement-related specialty solutions in clinical trials. For over a decade, ProPhase has focused on applying innovation to optimize the selection, use, and analysis of behavioral endpoints to mitigate trial risk and maximize the likelihood of study success.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2021 via GlobeNewswire

Syneos Health, acquired StudyKIK

synopsis: Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the acquisition of StudyKIK, a leading technology-enabled clinical trial recruitment and retention company.
buyer: Syneos Health (INCR:$4,730.38)
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Their company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. "
target: StudyKIK
StudyKIK is a leading technology-enabled clinical trial recruitment and retention company. StudyKIK supports patient recruitment, patient retention, eConsent Solutions, Telemedicine Video Calling, and study companion mobile applications to expedite clinical trials
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2005 via Company Press Release

Thomson Pharma, acquired Pharmaceutical Information Associates, Ltd.

synopsis: The Thomson Corporation announced that it has acquired Pharmaceutical Information Associates Ltd (PIA) and Astrolabe Analytica, Inc. (AAI). PIA and AAI are leading providers of regulatory consulting, marketing analytics and scientific communications services for the pharmaceutical industry.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma
Thomson Pharma is a dynamic, information offering for the pharmaceutical and biotechnology industries that is being developed by Thomson Scientific. "
target: Pharmaceutical Information Associates, Ltd.
Since 1990, Pharmaceutical Information Associates has supported the global drug development process by assisting with regulatory strategy development, the preparation of regulatory documentation, and the design, conduct, and audit of specialized clinical studies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/27/2013 via Company Press Release

PPD, Inc., acquired Acurian, Inc.

synopsis: Pharmaceutical Product Development, LLC, a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services, announced it has acquired Acurian, a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: Acurian, Inc.
Acurian, Inc. provides solutions needed to recruit, enroll, and retain patients for clinical trials. It offers recruitment feasibility, site identification and selection, patient recruitment and retention, and cancer solutions; and formulates a plan based on historical performance data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/5/2006 via PR Newswire

Ventiv Health, acquired Synergos, Inc.

synopsis: inVentiv Health, Inc. announced the completion of its acquisitions of Synergos, Inc., a focused clinical services provider, and Jeffrey Simbrow Associates Inc., Canada's leading healthcare marketing and communications agency. Both acquisitions were announced by inVentiv on March 13.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Synergos, Inc.
Synergos, Inc. is a functional service provider specializing in clinical trials management services, particularly project management and monitoring as well as investigator and patient recruitment. Synergos also provides regulatory affairs and quality compliance services.
price ($mm)
$5.75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Mango Health


read more

Mango Health

CareZone

DIMEC

PocketRx App

Kelinda

Healthnotes

Scriptcycle LLC

Prescribe Wellness

MedActionPlan.Com, LLC

Writi Inc.

Curisium

YouScript, Inc.

Prescribe Wellness

konciergeMD

Zipdrug, Inc.

Adaptive Software LLC

Landacorp, Inc.

Breakthrough Health

Kinesis Health Technologies

Omhu A/S

read more

Mango Health

read more

Mango Health

RxSolutions

read more

CFS Clinical

Tri Stat

Phlexglobal

Phlexglobal

Adjility Health

Octagon Research Solutions, Inc.

Clara Health

Invicro, LLC

Wincere, Inc.

ACI Clinical

Synchrogenix Information Strategies, Inc.

Behavioral Health Care Associates, Ltd.

Polaris Biopharma Consulting

Applied Clinical Intelligence

ProPhase, LLC

StudyKIK

Pharmaceutical Information Associates, Ltd.

Kinetiq

Acurian, Inc.

Synergos, Inc.

Geography
Matching Companies
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2021
rev ($mm)
$26.91
EBITDA ($mm)
($10.89)
EBIT ($mm)
($11.69)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: HLSE:HEALTH
 
 
 
 
 
 
 
 
Nightingale Health Plc
Nightingale Health Plc
Nightingale Health is a Finnish health technology company. Nightingale's mission is to bring disease prevention and a healthier life within everyone's reach. They offer a mobile blood testing platform that allows users to easily understand their current health and improve their wellbeing.
year
2020
rev ($mm)
$2.65
EBITDA ($mm)
($4.36)
EBIT ($mm)
($4.51)
Net Income ($mm)
Employees
77
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2022
rev ($mm)
$339.59
EBITDA ($mm)
($27.37)
EBIT ($mm)
($76.52)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2021
rev ($mm)
$1,158.07
EBITDA ($mm)
$194.47
EBIT ($mm)
$120.69
Net Income ($mm)
$74.78
Employees
8079
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2021
rev ($mm)
$221.66
EBITDA ($mm)
$54.10
EBIT ($mm)
$47.15
Net Income ($mm)
$38.31
Employees
1515
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:THNK
 
 
 
 
 
 
 
 
Think Research
Think Research
Think Research is an industry leader in delivering integrated digital healthcare solutions. Its evidence-based healthcare technology solutions support the clinical decision-making process, standardize care, and improve patient outcomes.
year
2021
rev ($mm)
$18.63
EBITDA ($mm)
($21.80)
EBIT ($mm)
($22.10)
Net Income ($mm)
Employees
189
  • drill down
  • watch
Ticker: K:HLYK
 
 
 
 
 
 
 
 
HealthLynked
HealthLynked
HealthLynked provides a solution for both patient members and providers to improve healthcare through the exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare.
year
2020
rev ($mm)
$4.84
EBITDA ($mm)
($2.77)
EBIT ($mm)
($2.87)
Net Income ($mm)
Employees
37
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch
Ticker: BSE:532890
 
 
 
 
 
 
 
 
TAKE Solutions, Inc.
TAKE Solutions, Inc.
TAKE Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management. Their range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums.
year
2018
rev ($mm)
$259.76
EBITDA ($mm)
$39.17
EBIT ($mm)
$33.43
Net Income ($mm)
$28.24
Employees
1500
  • drill down
  • watch
Ticker: WX
 
 
 
 
 
 
 
 
WuXi AppTec
WuXi AppTec
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States. WuXi AppTec provides a broad and integrated portfolio of services throughout the drug R&D process.
year
2014
rev ($mm)
$640.80
EBITDA ($mm)
$155.57
EBIT ($mm)
$108.53
Net Income ($mm)
$112.01
Employees
7445
  • drill down
  • watch
Ticker: AIM:C4XD
 
 
 
 
 
 
 
 
C4X Discovery
C4X Discovery aims to become the world’s most productive drug discovery and development company by exploiting cutting-edge technologies to design and create best-in-class drug candidates.
year
2015
rev ($mm)
$0.44
EBITDA ($mm)
($5.46)
EBIT ($mm)
($5.50)
Net Income ($mm)
Employees
19
  • drill down
  • watch
Ticker: XTRA:EVT
 
 
 
 
 
 
 
 
Evotec BioSystems GmbH
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.
year
2017
rev ($mm)
$226.46
EBITDA ($mm)
$53.38
EBIT ($mm)
$38.55
Net Income ($mm)
$40.69
Employees
1316
  • drill down
  • watch
Ticker: INCR
 
 
 
 
 
 
 
 
Syneos Health
Syneos Health
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Their company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities.
year
2021
rev ($mm)
$4,730.38
EBITDA ($mm)
$633.74
EBIT ($mm)
$407.86
Net Income ($mm)
$235.93
Employees
24310
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: MCK
 
 
 
 
 
 
 
 
McKesson Corporation
McKesson Corporation
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care.
year
2019
rev ($mm)
$214,319.00
EBITDA ($mm)
$4,229.00
EBIT ($mm)
$3,280.00
Net Income ($mm)
$34.00
Employees
70000
  • drill down
  • watch
Ticker: TSXV:IPA
 
 
 
 
 
 
 
 
ImmunoPrecise
ImmunoPrecise
ImmunoPrecise Antibodies (IPA) is a full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ single-cell interrogation technology, DeepDisplay™ custom phage libraries, as well as the Abthena™.
year
2021
rev ($mm)
$14.38
EBITDA ($mm)
($3.69)
EBIT ($mm)
($5.34)
Net Income ($mm)
Employees
73
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2019
rev ($mm)
$5,244.00
EBITDA ($mm)
$922.65
EBIT ($mm)
$524.54
Net Income ($mm)
$224.34
Employees
47427
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch